Jeffrey R. Marks
Affiliations: | Duke University, Durham, NC |
Area:
Molecular BiologyGoogle:
"Jeffrey Marks"Children
Sign in to add trainee| Edward K. Lobenhofer | grad student | 2000 | Duke |
| Rita Nahta | grad student | 2000 | Duke |
| Tammy J. Westmoreland | grad student | 2006 | Duke |
| Carrie A. Blanchette | grad student | 2007 | Duke |
| Hisani N. Horne | grad student | 2010 | Duke |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gosling SB, Arnold EL, Davies SK, et al. (2023) Microcalcification crystallography as a potential marker of DCIS recurrence. Scientific Reports. 13: 9331 |
| Strand SH, Rivero-Gutiérrez B, Houlahan KE, et al. (2022) Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts. Cancer Cell |
| Lips EH, Kumar T, Megalios A, et al. (2022) Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer. Nature Genetics. 54: 850-860 |
| Risom T, Glass DR, Averbukh I, et al. (2022) Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma. Cell. 185: 299-310.e18 |
| Stanton SE, Gad E, Ramos E, et al. (2021) Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients. Npj Breast Cancer. 7: 50 |
| Ryser MD, Mallo D, Hall A, et al. (2020) Minimal barriers to invasion during human colorectal tumor growth. Nature Communications. 11: 1280 |
| Lin CC, Mabe NW, Lin YT, et al. (2020) RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence. Cell Death and Differentiation |
| Adams D, Lin SH, Pass HI, et al. (2020) Circulating stromal cells as a potential blood-based biomarker for screening invasive solid tumors. Journal of Clinical Oncology. 38: 3535-3535 |
| Force JM, Taylor ML, Drusbosky L, et al. (2020) Identification of pathogenic ROS1 alterations in cell-free DNA (cfDNA) from patients with breast cancer. Journal of Clinical Oncology. 38: 1031-1031 |
| Force J, Sokol ES, Taylor ML, et al. (2020) Abstract P3-06-09: Incidence of ROS1 genomic alterations in breast cancer Cancer Research |